SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : genelabs(gnlb)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Chuca Marsh who wrote (182)2/14/2000 8:39:00 AM
From: Toni Wheeler  Read Replies (1) of 233
 
bigcharts.com

"The study showed that treatment with GL701 resulted in meaningful improvements in important clinical and quality of life measures for patients with lupus," said Dr. Mease. "No other drug currently being used for the treatment of lupus is both anti-inflammatory and capable of increasing bone density. We are enormously gratified to see such positive and compelling results for patients who suffer from this devastating disease yet have no adequate therapies."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext